Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

Rabheh Abdul Aziz, MD, MS

  • Lyme Arthritis on the Uptick in Western New York Area. Rabheh Abdul Aziz (Principal Investigator). Rheumatology Research Foundation. $1,000. 6/1/2018-8/1/2018.
  • Infection at Time of Presentation and During the Course of Juvenile Dermatomyositis. Rabheh Abdul Aziz (Principal Investigator). Rheumatology Research Foundation. $500. 6/1/2018-8/1/2018.

Stephanie Anzman-Frasca, PhD

  • Preventing Obesity Through Interventions During Infancy. Stephanie Anzman-Frasca (Principal Investigator). Pennsylvania State University. $59,798. 6/1/2018-3/1/2019.

Susan Baker, MD, PhD

  • Predicting Response to Standardized Pediatric Colitis Therapy: The PROTECT Study. Susan Baker (Principal Investigator). Connecticut Children‘s Medical Center. $26,605. 8/1/2012-4/1/2017.

Sara Berkelhamer, MD

  • Saving Lives at Birth. Sara Berkelhamer (Co-Investigator). USAID/Gates Foundation. $250,000. 7/1/2018-1/1/2020.
  • Targeted Antioxidant Therapy for the Treatment of BPD. Sara Berkelhamer (Principal Investigator). Wildermuth Research Foundation. $10,000. 5/1/2018-4/1/2019.

Kathleen Bethin, MD, PhD

  • T1D Exchange Clinic Registry Celiac Disease Additional Data Collection. Kathleen Bethin (Principal Investigator). Jaeb Center for Health Research. $9,091. 7/1/2014-10/1/2016.
  • Residual C-Peptide in Patients with Type 1 Diabetes. Kathleen Bethin (Principal Investigator). T1D Exchange. $9,545. 1/1/2012-1/1/2018.
  • Type 1 Diabetes TrialNet. Kathleen Bethin (Co-Investigator), Indrajit Majumdar (Co-Investigator), Teresa Quattrin (Principal Investigator). National Institutes of Health. $421,720. 9/1/2008-6/1/2018.

Gale Burstein, MD, MPH

  • NYSDOH Evaluation of Methods for Improving Screening for Chlamydia among Young Women Seen in Primary Care Settings. Gale Burstein (Co-Investigator). Centers for Disease Control and Prevention. $107,000. 1/1/2015-1/1/2017.

Melinda Cameron, MD

  • New York State Children‘s Environmental Health Center of Excellence. Melinda Cameron (Principal Investigator). Icahn School of Medicine at Mount Sinai. $125,000. 11/1/2017-10/1/2018.
  • Western New York Prevention Resource Center. Melinda Cameron (Principal Investigator). New York State Department of Health. $229,110. 1/1/1994-1/1/2021.

Praveen Chandrasekharan, MD

  • Optimizing Chest Compressions Targeting Gas Exchange and Hemodynamics in a Transitional Cardiac Arrest Model. Praveen Chandrasekharan (Principal Investigator). American Academy of Pediatrics. $15,000. 1/1/2018-12/1/2018.
  • Flush Volume and Epinephrine Pharmacokinetics. Praveen Chandrasekharan (Principal Investigator). American Academy of Pediatrics. $50,000. 1/1/2017-1/1/2019.
  • Rochester-Buffalo Neonatal Research Group. Praveen Chandrasekharan (Co-Investigator), Anne Marie Reynolds (Principal Investigator). University of Rochester. $300,025. 4/1/2016-3/1/2021.

Leonard Epstein, PhD

  • Enhancing Alternatives to Eating in Infants. Leonard Epstein (Co-Investigator), Kai Ling Kong (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,683,730. 8/1/2016-7/1/2021.
  • Can Reinforcing Alternatives to Food Prevent Weight Gain in Children?. Leonard Epstein (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $1,723,154. 8/1/2016-7/1/2021.
  • The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care – CCC – Lead Application. Leonard Epstein (Principal Investigator), Teresa Quattrin (Co-Investigator). National Institutes of Health. $5,615,697. 6/1/2016-5/1/2021.
  • Evaluating the Impact of Tobacco Control Policies in a Rapidly Changing Nicotine Delivery Market. Leonard Epstein (Principal Investigator). Virginia Polytechnic Institute and State University. $35,041. 4/1/2016-3/1/2021.
  • Clinical Translational Science Award (CTSA). Leonard Epstein (Co-Investigator), John Canty, Jr. (Co-Principal Investigator), Margarita Dubocovich (Principal Investigator), Peter Elkin (Co-Investigator), Steven Fliesler (Co-Investigator), Alan Hutson (Co-Investigator), Gene Morse (Co-Investigator), Sanjay Sethi (Co-Investigator), Laurene Tumiel Berhalter (Co-Investigator). National Institutes of Health. $16,000,000. 1/1/2016-1/1/2019.
  • Sensitization of the Reinforcing Value of Food as a Predictor of Weight Change in Adolescents. Leonard Epstein (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $1,993,750. 1/1/2016-1/1/2021.
  • Delay Discounting as a Target for Self-Regulation in Prediabetes. Leonard Epstein (Co-Principal Investigator), Lucy Mastrandrea (Co-Investigator), Teresa Quattrin (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $2,417,153. 9/1/2015-8/1/2020.
  • Using Prospection to Improve Obesity Treatment. Leonard Epstein (Principal Investigator), Teresa Quattrin (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,191,299. 1/1/2015-12/1/2019.
  • Food Marketing Vulnerability and Increased Risk for Weight Gain in Adolescents. Leonard Epstein (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $58,812. 1/1/2015-1/1/2018.

Howard Faden, MD

  • Research on C. difficile. Howard Faden (Principal Investigator). Wildermuth Foundation. $20,000. 1/1/2016-12/1/2016.

Danielle Goetz, MD

  • A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System. Danielle Goetz (Principal Investigator). Cincinnati Children's Hospital Medical Center. $76,950. 6/1/2017-12/1/2018.
  • Implementation of the Depression and Anxiety Guidelines: Award for a Mental Health Coordinator. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $121,384. 1/1/2016-12/1/2018.
  • TherapeuticS Development Center (TDC). Danielle Goetz (Co-Investigator), Carla Frederick (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $443,986. 1/1/2015-12/1/2018.
  • Additional Research Coordinator (ARC) Award. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $243,760. 1/1/2015-12/1/2018.
  • Success with Therapies Research Consortium. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation. $111,240. 8/1/2014-7/1/2018.
  • The EPIC Observational Longitudinal Assessment of Risk Factors For and Impact of Pseudomonas aeruginosa Acquisition and Early Anti-Pseudomonal Therapy in Children with Cystic Fibrosis. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $29,045. 3/1/2014-3/1/2019.

Oscar Gómez, MD, PhD

  • Studies on Emergent Diarrheagenic E. coli Pathogens. Oscar Gómez (Principal Investigator). National Institute of Allergy and Infectious Diseases. $675,282. 7/1/2016-11/1/2018.

Michelle Hartley-McAndrew, MD

Amanda Hassinger, MD, MS

  • A Single-Center Randomized Controlled Trial of Intravenous Fluid Content in Children with Diabetic Ketoacidosis Admitted to the Pediatric Intensive Care Unit. Amanda Hassinger (Principal Investigator). Wildermuth Research Foundation. $34,111. 5/1/2018-4/1/2019.
  • Decreasing Antibiotic Exposure in Infants with Suspected Ventilator-Associated Infection. Amanda Hassinger (Principal Investigator). Viriginal Commonwealth University. $675. 3/1/2017-11/1/2018.

Mark Hicar, MD, PhD

  • The Role of Non-Broadly Neutralizing Antibodies Targeting gp41 Structural Epitopes in Long-Term Nonprogression of HIV Infection. Mark Hicar (Principal Investigator). National Institute of Allergy and Infectious Diseases. $1,174,997. 2/1/2016-1/1/2021.

Lucy Holmes, MD, MPH

  • Project ASTHMA - Aligning with Schools To Help Manage Asthma. Lucy Holmes (Principal Investigator), Heather Lehman (Co-Investigator). University at Buffalo Clinical and Translational Science Institute. $49,650. 7/1/2018-6/1/2019.
  • Individual Development Awards Program. Lucy Holmes (Principal Investigator). United University Professions. $1,000. 1/1/2017-12/1/2017.

Shilpa Jain, MD, MPH

  • Genotype and Phenotype Analysis of Adolescents with Heavy Menstrual Bleeding and Low von Willebrand Activity. Shilpa Jain (Principal Investigator). Baylor College of Medicine. $300. 5/1/2017-5/1/2019.

James Jarvis, MD

  • Identifying Causal Variants in Juvenile Arthritis Using a Massively Parallel Reporter Assay. James Jarvis (Principal Investigator). National Institute of Arthritis and Musculoskeletal and Skin Diseases. $385,990. 9/1/2018-8/1/2020.
  • Genetics and Epigenetics in JIA CD4+ T Cells. James Jarvis (Principal Investigator). Rheumatology Research Foundation. $400,000. 7/1/2017-6/1/2019.
  • Developing Biomarkers for Juvenile Arthritis from Plasma Exosomes. James Jarvis (Principal Investigator). Wildermuth Foundation. $25,000. 6/1/2017-5/1/2018.
  • Interplay Between Genetics and Epigenetics in Polyarticular JIA. James Jarvis (Principal Investigator). Arthritis Foundation. $730,998. 12/1/2016-11/1/2018.
  • Plasma Exosomes in Juvenile Dermatomyositis. James Jarvis (Principal Investigator). Cure JM Foundation. $25,000. 7/1/2016-5/1/2018.
  • Arthritis Small Grant - Equipment. James Jarvis (Principal Investigator). Fraternal Order of Eagles. $3,344. 6/1/2015-5/1/2019.
  • Arthritis Small Grant - Gift Cards. James Jarvis (Principal Investigator). Fraternal Order of Eagles. $1,000. 6/1/2015-5/1/2019.

Kara Kelly, MD

  • Genetic Underpinnings of Ethnic Disparities in Bone Toxicities Between Hispanic and Non-Hispanic Children Treated for Acute Lymphoblastic Leukemia. Kara Kelly (Co-Principal Investigator). National Cancer Institute. $200,000. 12/1/2017-11/1/2019.
  • The Influence of Social Network Size, Composition and Function on Psychological Outcomes of Pediatric Cancer Caregiving: Relationships Across Time and Around Periods of Distress. Kara Kelly (Co-Investigator). National Cancer Institute. $722,488. 6/1/2017-6/1/2022.
  • A Comprehensive Assessment of Oral Chemotherapy Adherence in Pediatric ALL. Kara Kelly (Co-Principal Investigator). Roswell Park Alliance Foundation. $50,000. 6/1/2017-6/1/2018.

Jeremy Killion, MD

  • A Study Examining Visualization of the Larynx in Difficult Intubations Using a Specialized Device Called the “D-Blade”. Jeremy Killion (Co-Principal Investigator). Wildermuth Foundation. $4,929. 1/1/2017-12/1/2017.

Kai Ling Kong, PhD

  • Enhancing Alternatives to Eating in Infants. Kai Ling Kong (Co-Investigator), Leonard Epstein (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,683,730. 8/1/2016-7/1/2021.
  • Developing the Methodology to Measure Food Reward in Young Infants (3-6 months old). Kai Ling Kong (Principal Investigator). University at Buffalo IMPACT. $21,000. 2/1/2016-2/1/2017.
  • Methodology to Measure Infant Food Reinforcement. Kai Ling Kong (Principal Investigator). Research Institute on Addictions. $24,491. 11/1/2015-10/1/2016.
  • CTSA Pilot: Pilot Study on Pediatric Obesity Prevention by Maternal Smoking Cessation in Pregnancy and Lactation. Kai Ling Kong (Co-Investigator), Xiaozhong Wen (Principal Investigator). National Institutes of Health. $75,000. 11/1/2015-3/1/2017.

Bree Kramer, DO

  • The Use of Near-infrared Spectroscopy in Children with Traumatic Brain Injury to Predict Adverse Events. Bree Kramer (Principal Investigator). Wildermuth Foundation. $9,600. 1/1/2018-1/1/2019.
  • Transmitted Lung Pressure Values with Biphasic Chest Cuirass. Bree Kramer (Principal Investigator). Kaleida Health Foundation. $4,000. 1/1/2018-1/1/2019.

Vasanth Kumar, MD

  • Regulation of PDE3 in the Pathobiology of Pulmonary Hypertension. Vasanth Kumar (Principal Investigator). National Heart, Lung, and Blood Institute. $44,536. 9/1/2017-8/1/2022.

Dennis Kuo, MD, MHS

  • Medical Director, American Academy of Pediatrics Chapter Quality Network. Dennis Kuo (Principal Investigator). American Academy of Pediatrics. $50,000. 3/1/2018-2/1/2020.
  • DANY Ambulatory Care Training Enhancement Program Award. Dennis Kuo (Co-Investigator). New York State. $595,743. 1/1/2018-6/1/2021.
  • Community-Based Integrated Service Systems. Dennis Kuo (Principal Investigator). New York State Office of Children and Family Services. $97,933. 8/1/2017-7/1/2021.
  • Building Health Through Care Coordination for Children with Medical Complexity. Dennis Kuo (Principal Investigator). Lucille Packard Foundation for Children‘s Health. $68,903. 5/1/2017-8/1/2018.

Heather Lehman, MD, FAAAI

  • Project ASTHMA - Aligning with Schools To Help Manage Asthma. Heather Lehman (Co-Investigator), Lucy Holmes (Principal Investigator). University at Buffalo Clinical and Translational Science Institute. $49,650. 7/1/2018-6/1/2019.
  • Defining and Treating a New Pediatric Asthma Endotype: Depression-Related Asthma Mediated by the Cholinergic Pathway. Heather Lehman (Principal Investigator). University at Buffalo. $47,000. 7/1/2016-6/1/2017.
  • Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators. Heather Lehman (Co-Investigator), Bruce Miller (Principal Investigator), Beatrice Wood (Principal Investigator). NIH/NHLBI. $3,987,363. 8/1/2015-7/1/2020.

Indrajit Majumdar, MBBS

  • A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents with Type 2 Diabetes and Clinical Study. Indrajit Majumdar (Co-Investigator), Lucy Mastrandrea (Principal Investigator). AstraZeneca. 1/1/2017-1/1/2020.
  • Targeting Polyamines Using DFMO in Persons with T1D. Indrajit Majumdar (Co-Investigator), Lucy Mastrandrea (Co-Principal Investigator). Indiana University Board of Trustees. $48,953. 12/1/2016-5/1/2019.
  • A 6-Month, Multi-Center, Randomized, Open-Label, 2-Arm, Parallel Group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus Injected Once Daily in Children and Adolescents with Type 1 Diabetes. Indrajit Majumdar (Co-Investigator), Lucy Mastrandrea (Principal Investigator). Sanofi. 12/1/2016-12/1/2018.
  • Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects with Obesity. A 56-Week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Multi-National Trial. Indrajit Majumdar (Co-Investigator), Lucy Mastrandrea (Principal Investigator). NovoNordisk. 11/1/2016-11/1/2018.
  • Type 1 Diabetes TrialNet. Indrajit Majumdar (Co-Investigator), Kathleen Bethin (Co-Investigator), Teresa Quattrin (Principal Investigator). National Institutes of Health. $421,720. 9/1/2008-6/1/2018.

Lucy Mastrandrea, MD, PhD

  • A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents with Type 2 Diabetes and Clinical Study. Lucy Mastrandrea (Principal Investigator), Indrajit Majumdar (Co-Investigator). AstraZeneca. 1/1/2017-1/1/2020.
  • Targeting Polyamines Using DFMO in Persons with T1D. Lucy Mastrandrea (Co-Principal Investigator), Indrajit Majumdar (Co-Investigator). Indiana University Board of Trustees. $48,953. 12/1/2016-5/1/2019.
  • A 6-Month, Multi-Center, Randomized, Open-Label, 2-Arm, Parallel Group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus Injected Once Daily in Children and Adolescents with Type 1 Diabetes. Lucy Mastrandrea (Principal Investigator), Indrajit Majumdar (Co-Investigator). Sanofi. 12/1/2016-12/1/2018.
  • Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects with Obesity. A 56-Week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Multi-National Trial. Lucy Mastrandrea (Principal Investigator), Indrajit Majumdar (Co-Investigator). NovoNordisk. 11/1/2016-11/1/2018.
  • A 24-Week, Multicenter, Randomized, Double-Blind, Parallel Group, Phase 3 Trial with a 28-Week Long-Term Safety Extension Phase Evaluating the Safety and Efficacy of Dapagliflozin 10 mg in T2DM Subjects Age 10-24 Years. Lucy Mastrandrea (Principal Investigator). AstraZeneca. 9/1/2016-9/1/2018.
  • Delay Discounting as a Target for Self-Regulation in Prediabetes. Lucy Mastrandrea (Co-Investigator), Leonard Epstein (Co-Principal Investigator), Teresa Quattrin (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $2,417,153. 9/1/2015-8/1/2020.

Jayasree Nair, MD

  • Delayed Cord Clamping in Term Lambs with Asystolic Cardiac Arrest. Jayasree Nair (Principal Investigator). American Academy of Pediatrics. $50,000. 1/1/2018-12/1/2018.
  • Role of Sustained Inflation and Delayed Cord Clamping in Resuscitation after Asphyxia. Jayasree Nair (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $159,500. 7/1/2016-6/1/2018.

Teresa Quattrin, MD

  • Phase 2 SIMPONI to Arrest B-cell Loss in Type 1 Diabetes. Teresa Quattrin (Principal Investigator). Janssen Research and Development, LLC. $66,371. 1/1/2017-1/1/2019.
  • The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care – CCC – Lead Application. Teresa Quattrin (Co-Investigator), Leonard Epstein (Principal Investigator). National Institutes of Health. $5,615,697. 6/1/2016-5/1/2021.
  • Delay Discounting as a Target for Self-Regulation in Prediabetes. Teresa Quattrin (Co-Investigator), Leonard Epstein (Co-Principal Investigator), Lucy Mastrandrea (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $2,417,153. 9/1/2015-8/1/2020.
  • Using Prospection to Improve Obesity Treatment. Teresa Quattrin (Co-Investigator), Leonard Epstein (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,191,299. 1/1/2015-12/1/2019.
  • Type 1 Diabetes TrialNet. Teresa Quattrin (Principal Investigator), Kathleen Bethin (Co-Investigator), Indrajit Majumdar (Co-Investigator). National Institutes of Health. $421,720. 9/1/2008-6/1/2018.

Munmun Rawat, MD

  • Use of Vasopressin in Neonatal Resuscitation. Munmun Rawat (Principal Investigator). Canadian Paediatric Society. $9,602. 10/1/2016-11/1/2018.

Anne Marie Reynolds, MD, MPH

  • Developmental Impact of NICU Exposures (DINE). Anne Marie Reynolds (Principal Investigator). Albert Einstein College of Medicine. $102,849. 9/1/2017-8/1/2018.
  • Rochester-Buffalo Neonatal Research Group. Anne Marie Reynolds (Principal Investigator), Praveen Chandrasekharan (Co-Investigator). University of Rochester. $300,025. 4/1/2016-3/1/2021.
  • Neonatal Research Network. Anne Marie Reynolds (Co-Principal Investigator), Osman Farooq (Co-Investigator), Michelle Hartley-McAndrew (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. 4/1/2011-4/1/2021.

Beverly Schaefer, MD

  • Impact of Obesity on Laboratory Profiles, Treatment and Outcomes of Individuals with Type 1 Von Willebrand Disease and Low Von Willebrand Factor. Beverly Schaefer (Principal Investigator). American Thrombosis and Hemostasis Network. $50,000. 7/1/2018-6/1/2019.
  • Robert Long Career Development Award. Beverly Schaefer (Principal Investigator). Hemophilia Center of Western New York. $890,000. 1/1/2018-1/1/2022.

Xiaozhong Wen, PhD

  • Postpartum Smoking Relapse Prevention by Breastfeeding Promotion. Xiaozhong Wen (Principal Investigator). National Institutes of Health. $242,324. 8/1/2018-7/1/2020.
  • Maternal and Child Health Field-Initiated Research Program. Xiaozhong Wen (Principal Investigator). Health Resources and Services Administration. $99,995. 7/1/2018-6/1/2019.
  • CTSA Pilot: Pilot Study on Pediatric Obesity Prevention by Maternal Smoking Cessation in Pregnancy and Lactation. Xiaozhong Wen (Principal Investigator), Kai Ling Kong (Co-Investigator). National Institutes of Health. $75,000. 11/1/2015-3/1/2017.

Jamie Wooldridge, MD

  • PROSPECT GI pH Sub-Study and GIFT Breath Testing Sub-Study. Jamie Wooldridge (Principal Investigator). Cystic Fibrosis Foundation Therapeutics. $311,367. 7/1/2014-6/1/2018.